BC
NUVL

Boxer Capital’s Nuvalent NUVL Stock Holding History

Boxer Capital’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,120,192
Closed -$115M – 35
2024
Q3 		$115M Hold
1,120,192
– – 5.62% 3
2024
Q2 		$85M Hold
1,120,192
– – 4.48% 7
2024
Q1 		$84.1M Hold
1,120,192
– – 4.15% 9
2023
Q4 		$82.4M Sell
1,120,192
-90,000
-7% -$5.57M 4.11% 9
2023
Q3 		$55.6M Hold
1,210,192
– – 2.96% 12
2023
Q2 		$51M Hold
1,210,192
– – 2.37% 15
2023
Q1 		$31.6M Hold
1,210,192
– – 1.55% 19
2022
Q4 		$36M Hold
1,210,192
– – 1.9% 18
2022
Q3 		$23.5M Hold
1,210,192
– – 1.32% 27
2022
Q2 		$16.4M Hold
1,210,192
– – 1.04% 33
2022
Q1 		$16.8M Hold
1,210,192
– – 0.86% 36
2021
Q4 		$23M Hold
1,210,192
– – 0.89% 29
2021
Q3 		$27.3M Buy
+1,210,192
New +$35.1M 0.95% 31

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Boxer Capital's NUVL Position: Q4 2024 in Review

Boxer Capital sold out of Nuvalent (NUVL) in Q4 2024, closing a stake of 1,120,192 shares — an estimated $115M sold.

Boxer Capital first reported a position in NUVL in Q3 2021 and held it in 13 quarters. The position peaked at $115M in Q3 2024. 216 funds tracked by Wall St. Rank hold NUVL as of Q4 2024.

  • Boxer Capital reported no remaining Nuvalent position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 1,120,192 Nuvalent shares in Q4 2024, an estimated $115M.
  • Boxer Capital first reported a position in Nuvalent in Q3 2021 and held it in 13 quarters.
  • Boxer Capital's Nuvalent position peaked at $115M in Q3 2024.
  • 216 funds tracked by Wall St. Rank held Nuvalent as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.